L. Stein Gold, M. Lebwohl, N. . Bhatia, D. DiRuggiero, A. Jacobson, and R. Pillai, “Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion”, J of Skin, vol. 4, no. 6, p. s79, Oct. 2020.